Prevalence of arteriovenous fistulas in incident hemodialysis patients: Correlation with patient factors that may be associated with maturation failure

American Journal of Kidney Diseases

Volumn 59, Issue 4, 2012, Pages 541-549

  Lilly, Michael P ^a   Lynch, Janet R ^b   Wish, Jay B ^c   Huff, Edwin D ^d   Chen, Shu Cheng ^e   Armistead, Nancy C ^b   McClellan, William M ^f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Mid Atlantic Renal Coalition   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Centers for Medicare and Medicaid Services   (United States)

^e MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTERIOVENOUS FISTULA; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HEALTH INSURANCE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEPHROLOGIST; OBESITY; OUTPATIENT; PERIPHERAL VASCULAR DISEASE; PREDICTION; PREVALENCE; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; TREATMENT FAILURE; VASCULAR ACCESS;

AGED; AGED, 80 AND OVER; ARTERIOVENOUS ANASTOMOSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MODELS, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES;

EID: 84862809433     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.11.038     Document Type: Article

References (41)

1. Fistula First Breakthrough Initiative. Fistula First prevalent US data. http://www.fistulafirst.org/AboutFistulaFirst/FFBIData.aspx. Accessed January 23, 2012.
2. Lynch JR,Wasse H, Armistead NC, McClellan WM.Achieving the goal of the Fistula First Breakthrough Initiative for prevalent maintenance hemodialysis patients. Am J Kidney Dis. 2011; 57(1):78-89.
3. Ravani P, Spergel LM, Asif A, Roy-Chaudhury P, Besarab A. Clinical epidemiology of arteriovenous fistula in 2007. J Nephrol. 2007;20(2):141-149. (Pubitemid 47072397)
4. McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV. Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol. 2009;20(5):1078-1085.
5. Goodkin DA, Pisoni RL, Locatelli F, Port FK, Saran R. Hemodialysis vascular access training and practices are key to improved access outcomes. Am J Kidney Dis. 2010;56:1032-1042.
6. Kiaii M, MacRae JM. A dedicated vascular access program can improve arteriovenous fistula rates without increasing catheters. J Vasc Access. 2008;9(4):254-259.
7. Flu H, Breslau PJ, Straaten JMK-v, Hamming JF, Lardenoye J-WH. The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery. J Vasc Surg. 2008;48(3):659-668.
8. Huijbregts HJTAM, Bots ML, Moll FL, Blankestijn PJ. Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas. J Vasc Surg. 2007;45(5):962-967. (Pubitemid 46634924)
9. O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007; 18(10):2758-2765. (Pubitemid 47531203)
10. Ethier J, Mendelssohn DC, Elder SJ, et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23(10):3219-3226.
11. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002; 62(4):1109-1124.
12. Saran R, Dykstra DM, Pisoni RL, et al. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant. 2004;19(9):2334-2340.
13. van Loon MM, Kessel AGH, van der Sande FM, Tordoir JHM. Cannulation practice patterns in haemodialysis vascular access: predictors for unsuccessful cannulation. J Ren Care. 2009; 35(2):82-89.
14. Ravani P, Barrett B, Mandolfo S, et al. Factors associated with unsuccessful utilization and early failure of the arterio-venous fistula for hemodialysis. J Nephrol. 2005;18(2):188-196. (Pubitemid 40852622)
15. Agarwal AK. Central vein stenosis: current concepts. Adv Chronic Kidney Dis. 2009;16(5):360-370.
16. Hurst FP, Abbott KC, Raj D, et al. Arteriovenous fistulas among incident hemodialysis patients in Department of Defense and Veterans Affairs facilities. J Am Soc Nephrol. 2010;21(9):1571-1577.
17. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17(11):3204-3212. (Pubitemid 44707782)
18. Centers for Disease Control and Prevention. About BMI for adults. http://www.cdc.gov/healthyweight/assessing/bmi/adult-bmi/index.html. Accessed August 19, 2010.
19. Penman AD, Johnson WD. The changing shape of the body mass index distribution curve in the population: implications for public health policy to reduce the prevalence of adult obesity. Prev Chronic Dis [serial online]. 2006;3(3):A74.
20. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health. 2007;121(7):492-496. (Pubitemid 46895458)
21. Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial. 2003;16(3):189-196. (Pubitemid 37363218)
22. Brown PW. Preoperative radiological assessment for vascular access. Eur J Vasc Endovasc Surg. 2006;31(1):64-69. (Pubitemid 43024986)
23. Hyland K, Cohen RM, Kwak A, et al. Preoperative mapping venography in patients who require hemodialysis access: imaging findings and contribution to management. J Vasc Intervent Radiol. 2008;19(7):1027-1033.
24. Lauvao LS, Ihnat DM, Goshima KR, Chavez L, Gruessner AC, Mills JL Sr. Vein diameter is the major predictor of fistula maturation. J Vasc Surg. 2009;49:1499-1504.
25. Silva JMB, Hobson Ii RW, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg. 1998; 27(2):302-308. (Pubitemid 28136810)
26. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis. 2004;44(suppl 2):22-26.
27. Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2002;61(6):2266-2271. (Pubitemid 34539345)
28. Xi W, MacNab J, Lok CE, et al. Who should be referred for a fistula? A survey of nephrologists. Nephrol Dial Transplant. 2010;25(8):2644-2651.
29. Astor BC, Eustace JA, Powe NR, et al. Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis. 2001;38(3):494-501. (Pubitemid 32803059)
30. Avorn J,Winkelmayer WC, Bohn RL, et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002;55(7):711-716. (Pubitemid 34831061)
31. Sprangers B, Evenepoel P, Vanrenterghem Y. Late referral of patients with chronic kidney disease: no time to waste. Mayo Clin Proc. 2006;81(11):1487- 1494. (Pubitemid 44685014)
32. Mid-Atlantic Renal Coalition. Fistula First Breakthrough Initiative Strategic Plan, 2009. http://www.fistulafirst.org/AboutFistulaFirst/ PresentationsReports.aspx. Accessed August 19, 2010.
33. Kakkos SK, Haddad GK, Stephanou A, Haddad JA, Shepard AS. Routine preoperative venous and arterial mapping increases both construction and maturation rate of upper arm autogenous arteriovenous fistulae. Vasc Endovasc Surg. 2011;45(2):135-141.
34. Allon M, Lockhart ME, Lilly RZ, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int. 2001;60(5):2013-2020. (Pubitemid 33000008)
35. Choi HM, Lal BK, Cerveira JJ, et al. Durability and cumulative functional patency of transposed and nontransposed arteriovenous fistulas. J Vasc Surg. 2003;38(6):1206-1211.
36. Miller GA, Goel N, Khariton A, et al. Aggressive approach to salvage non-maturing arteriovenous fistulae: a retrospective study with follow up. J Vasc Access. 2009;10:183-191.
37. Fistula First Breakthrough Initiative. Thirteen change concepts for increasingAV fistulas. http://fistulafirst.org/Professionals/FFBIChangeConcepts. aspx. Accessed May 19, 2011.
38. Kanda E, Krisher JO, McClellan WM, Bond TC. Better agreement between incident arteriovenous fistula status on the Centers for Medicare & Medicaid CMS-2728 Form and Medicare claims identifies facilities with better quality of pre-dialysis care [TH-PO572]. ASN Renal Week 2010. http://www.abstracts2view. com/asn/. Accessed January 25, 2011.
39. Layton JB, Hogan SL, Kenderes CE, Krisher J, Jennette JC, McClellan WM. Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol. 2010;5(11):2046-2052.
40. Longenecker JC, Coresh J, Klag MJ, et al. Validation of comorbid conditions on the End-Stage Renal Disease Medical Evidence Report: the CHOICE Study. J Am Soc Nephrol. 2000;11:520-529. (Pubitemid 30115082)
41. Eggers PW. CMS 2728: what good is it? Clin J Am Soc Nephrol. 2010;5:1908-1909.